Antagonists of A2B Receptors Improve Insulin Sensitivity

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 2R44DK059677-02
Agency Tracking Number: 1R43DK059677-01
Amount: $1,424,440.00
Phase: Phase II
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
310 FOURTH STREET NE, SUITE 201, CHARLOTTESVILLE, VA, 22902
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 ROBERT Figler
 (434) 924-5427
 RAF@ADENRX.COM
Business Contact
Phone: (434) 220-9400
Email: ROB@ADENRX.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): This is a phase II SBIR grant to develop a new therapy for the treatment of type II diabetes. Adenosine Therapeutics, LLC (ATL) is a biotechnology company started in Charlottesville, Virginia in 1999. ATL owns patents

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government